Why the study?
Does α-hANP affect coronary circulation and myocardial contractility in open-chest dogs?
Does α-hANP affect coronary circulation and myocardial contractility in open-chest dogs?
Answers are grounded in this paper and cite their sources.
In a canine model, α-hANP acts as a coronary vasodilator without exerting direct inotropic effects on the myocardium.
The effect of synthetic human atrial 28-amino acid peptide (α-human atrial natriuretic polypeptide, α-hANP) on coronary circulation and cardiac functions were examined in openchest dogs. Continuous infusion of α-hANP into the left anterior descending coronary artery (LAD) increased blood flow of the LAD in a dosedependent manner. Linear regression analysis revealed the relationship as logit (changes in mean coronary conductance (MCC)=1.45×log (coronary plasma concentration of α-hANP)+7.51, (r=0.87, n=29). REC50 of α-hANP was 5.1×10-6M, where REC50 was the concentration to increase MCC to a half maximum MCC during reactive hyperemia after a 30-second coronary occlusion. A force straingauge arch was inserteed directly onto the myocardium supplied by the LAD. Indices of myocardial contractility measured, myocardial force (F), max dF/dt and LVmax dp/dt, were not altered by either bolus intravenous injection or continuous intracoronary infusion of α-hANP. These results suggest that α-hANP increased coronary conductance, but did not change myocardial contractility.
No takes yet. Share an insight, caveat, or question.
Akinori Shimizu (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: